← back to search

Nai‐Ying Zheng

Cornell University · US
Area of research
Immunology · Epidemiology
Research interest
Research interests include Influenza Virus Research Studies, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Monoclonal and Polyclonal Antibodies Research.
h-index
29
citations
7,034
works
73
NIH funding
primary concept
email

Recent publications

Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
Nature Communications 2025cited by 17position: middledoi
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Journal of Clinical Investigation 2023cited by 14position: middledoi
Broadly neutralizing antibodies target a haemagglutinin anchor epitope
Nature 2021cited by 185position: middledoi
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes
Science Translational Medicine 2021cited by 78position: middledoi
An Egg-Derived Sulfated <i>N</i> -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines
mBio 2021cited by 20position: middledoi
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans
Science Translational Medicine 2020cited by 128position: middledoi
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses
Immunity 2020cited by 96position: middledoi
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Cell 2019cited by 575position: middledoi
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
Nature Microbiology 2019cited by 100position: middledoi
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study
Journal of Virology 2019cited by 26position: middledoi
Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination
Journal of Clinical Investigation 2018cited by 48position: middledoi
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Cell Host & Microbe 2016cited by 276position: middledoi
B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts
Journal of Virology 2016cited by 124position: middledoi
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Journal of Clinical Investigation 2015cited by 131position: middledoi
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination
PLoS ONE 2015cited by 35position: middledoi
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season
Proceedings of the National Academy of Sciences 2014cited by 238position: middledoi
<i>Staphylococcus aureus</i> infection induces protein A–mediated immune evasion in humans
The Journal of Experimental Medicine 2014cited by 151position: middledoi
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
Proceedings of the National Academy of Sciences 2012cited by 404position: middledoi
High abundance of plasma cells secreting transglutaminase 2–specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions
Nature Medicine 2012cited by 210position: middledoi
Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice
mBio 2012cited by 77position: middledoi
Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis
Immunobiology 2012cited by 32position: middledoi
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
Vaccine 2012cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Patrick C. Wilson · University of Lethbridge17 papers (2012–2025)Min Huang · China Agricultural University13 papers (2012–2025)Florian Krammer · Semmelweis University7 papers (2015–2021)Rafi Ahmed · Emory University6 papers (2012–2016)Peter Palese · University of Szeged5 papers (2015–2021)Jens Wrammert · Emory University5 papers (2012–2016)Jenna J. Guthmiller · University of Colorado Anschutz Medical Campus4 papers (2018–2021)Carole Henry · Université de Rouen Normandie4 papers (2018–2021)Henry A. Utset · University of Chicago4 papers (2019–2021)Irvin Y. Ho · University of Chicago3 papers (2015–2019)Carole J. Henry Dunand · University of Chicago3 papers (2015–2016)Kaval Kaur · Agency for Science, Technology and Research3 papers (2014–2015)Micah E. Tepora · University of Chicago3 papers (2018–2021)Yao-Qing Chen · Fujian Medical University3 papers (2019–2020)Karlynn E. Neu · Boston University3 papers (2018–2020)Sarah F. Andrews · National Institutes of Health3 papers (2012–2014)Yunping Huang · Ningbo Academy of Agricultural Sciences3 papers (2014–2015)Sarah Cobey · Ecologie & Evolution3 papers (2018–2021)Jane-Hwei Lee · University of Chicago3 papers (2012–2015)Judith A. James · Oklahoma Medical Research Foundation3 papers (2012–2015)